A new drug developed by scientists at the Florey Institute of Neuroscience, and the School of Chemistry and Bio21 Institute at the University of Melbourne has dramatically improved clinical and cognitive symptoms of motor neurone disease, also called amyotrophic lateral sclerosis.
Motor neurone disease is a progressive, fatal neurodegenerative disease. Its key hallmark is the death of the brain cells that control muscle movements. This results in muscle weakness and eventually paralysis.
Patients usually die of respiratory failure within three years of diagnosis, and there are no treatments or disease-modifying therapies available.
In this dose-finding trial involving 32 patients, the group given the highest amount of the CuATSM compound showed improved lung function and cognitive ability, compared to the predicted declines observed in standard-of-care patients.
Further, treated patients showed a much slower overall disease progression as measured by a global disability score.
The clinical trial was led by Professor Dominic Rowe at Macquarie University, and Associate Professor Susan Mathers at Calvary Health Care Bethlehem, and sponsored by Collaborative Medicinal Development Pty Ltd with support from FightMND.
Professor Ashley Bush, Chief Scientific Officer of Collaborative Medicinal Development and director of the Melbourne Dementia Research Centre, said “This is the first human evidence for a disease-modifying drug for motor neurone disease. It is a huge breakthrough, and we look forward to confirming the positive results in a larger study soon.”
Associate Professor Kevin Barnham of the Florey, Associate Professor Anthony White at the Queensland Institute of Medical Research, and Professor Paul Donnelly and Associate Professor Peter Crouch from the University of Melbourne, developed and tested CuATSM over a 15-year period.
After showing its therapeutic potential for motor neurone disease in pre-clinical models, the researchers founded a company and licenced the compound to Collaborative Medicinal Development, to take the drug into human studies.
Professor Donnelly said, “It is gratifying to see such promising results made possible by collaborative fundamental research at the interface between chemistry and biology.”
The Latest on: Motor neurone disease
via Google News
The Latest on: Motor neurone disease
- It takes a village to fight this horrible disease. Help find a cure for ALS (Lou Gehrig’s Disease) | Opinionon October 15, 2019 at 8:52 am
Cancer? How about ALS? ALS (Amyotrophic Lateral Sclerosis disease), often referred to as Lou Gehrig’s Disease, is a progressive, neurodegenerative disease that kills motor neurons, robbing a person of ...
- Neurobiology and Therapeutic Targets of Parkinson’s Diseaseon October 15, 2019 at 1:36 am
The diagnosis of this disease is based on the occurrence of bradykinesia, unilateral or asymmetric resting tremor, and rigidity. These motor features are caused when dopaminergic neurons degenerate in ...
- Scientist With Motor Neurone Disease Turning Himself Into 'Full Cyborg'on October 14, 2019 at 1:24 am
A scientist who was diagnosed with terminal motor neurone disease hopes to 'transform' into the world's first true cyborg. Advert Now, Dr Peter Scott-Morgan, who was given until this year to live ...
- Motor neurone disease fundraising: one family’s fight for lifeon October 13, 2019 at 10:09 pm
Motor neurone disease has affected the Churm family for generations, and there is no knowing when the deadly condition will strike next. Now the Churms are fighting back. Patricia and Cecil Churm ...
- Terminally-ill scientist with motor neurone disease ‘transforms into world’s first cyborg’ by replacing body parts with machineryon October 12, 2019 at 11:17 am
A dying scientist battling motor neurone disease has become the world’s first full cyborg. Dr Peter Scott-Morgan, 61, was diagnosed with the muscle wasting illness two years ago but instead of ...
- Terminally-ill scientist with motor neurone disease ‘transforms into world’s first full cyborg’on October 12, 2019 at 7:55 am
A SCIENTIST battling motor neurone disease has spoken of his transition to the "world's first full cyborg". Dr Peter Scott-Morgan, 61, was diagnosed with the muscle-wasting illness in 2017 - and only ...
- 'I'm not ready to bring her back' - NZ not safe for three-year-old with motor neuron disease, mum sayson October 10, 2019 at 12:11 am
Charlotte and her family have uprooted their lives from Auckland, leaving behind extended family and friends, to start a life in Australia so that she can get access to the treatment for her motor ...
- Emerging Therapeutics for Neurodegenerative Diseases Part II: Huntington's Disease and Amyotrophic Lateral Sclerosis (HD & ALS)on October 7, 2019 at 6:20 am
utm_source=PRN At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized economy.Overall characterized by a loss of neurons in particular regions of ...
- The necroptosis machinery mediates axonal degeneration in a model of Parkinson diseaseon October 7, 2019 at 2:23 am
Parkinson’s disease (PD) is the second most common neurodegenerative condition, characterized by motor impairment due to the progressive degeneration of dopaminergic neurons in the substantia nigra ...
- Motor Neurone Disease: Artist with same disease as Stephen Hawking paints with eyeson October 5, 2019 at 3:01 pm
Like Professor Hawking, Sarah Ezekiel and Miles Pilling “won the lottery of MND” by having the variant that allows them to live longer. Motor neurone disease affects the brain and spinal cord causing ...
via Bing News